Literature DB >> 86771

Oestrogen receptors and prognosis in early breast cancer.

T Cooke, D George, R Shields, P Maynard, K Griffiths.   

Abstract

In a study of the role of oestrogen-receptor analysis in early breast cancer the oestrogen-receptor content of the tumour was estimated in 286 patients undergoing mastectomy. These patients were followed for up to 39 months, and the recurrence of disease was noted in relation to the presence or absence of oestrogen receptor.Recurrence-rates were significantly higher in patients whose tumours did not contain receptors than in those whose tumours did. This same relationship was seen when women with and without axillary metastases were considered separately. The highest rates of recurrence were in women with axillary lymph-node involvement whose tumours lacked oestrogen receptors. Women without axillary-node involvement whose tumours lacked oestrogen receptors showed the same high rate of recurrence as all women with axillary-node involvement. The oestrogen-receptor content of a primary breast cancer appears to be an independent guide to early recurrence of the disease.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 86771     DOI: 10.1016/s0140-6736(79)92752-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  35 in total

1.  Oestrogen receptor values and histologic type and grade in breast carcinoma--a three year review.

Authors:  B M Loftus; C E Connolly
Journal:  Ir J Med Sci       Date:  1988-02       Impact factor: 1.568

2.  Anti-estrogen treatment of postmenopausal breast cancer patients with high risk of recurrence: 72 months of life-table analysis and steroid hormone receptor status.

Authors:  C Rose; H T Mouridsen; S M Thorpe; J Andersen; M Blichert-Toft; K W Andersen
Journal:  World J Surg       Date:  1985-10       Impact factor: 3.352

3.  Progesterone receptor as a more reliable prognostic parameter than estrogen receptor in patients with advanced breast cancer.

Authors:  H Magdelénat; P Pouillart; M Jouve; T Palangié; E Garcia Giralt; B Bretaudeau; B Asselain
Journal:  Breast Cancer Res Treat       Date:  1982       Impact factor: 4.872

4.  Disease-free interval and estrogen receptor activity in tumor tissue of patients with primary breast cancer: analysis after long-term follow-up.

Authors:  J M Raemaekers; L V Beex; A J Koenders; G F Pieters; A G Smals; T J Benraad; P W Kloppenborg
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

5.  An immunohistological study of breast cancer--with special reference to the expression of carbohydrate antigens and estrogen receptor status.

Authors:  M Sowa; Y S Chung; Y Kato; M Nishimura; T Kubo; H Maekawa; Y Fujimoto; K Umeyama; M Kawahara
Journal:  Jpn J Surg       Date:  1990-05

6.  Relationship between ER-ICA and conventional steroid receptor assays in human breast cancer.

Authors:  G Di Fronzo; C Clement; V Cappelletti; P Miodini; D Coradini; E Ronchi; S Andreola; F Rilke
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

7.  Estrogen receptor status of breast cancer in Ontario.

Authors:  G E McKeown-Eyssen; I Rogers-Melamed; E A Clarke
Journal:  CMAJ       Date:  1985-11-15       Impact factor: 8.262

8.  Animal models for hormone-dependent human breast cancer. Relationship between steroid receptor profiles in canine and feline mammary tumors and survival rate.

Authors:  P M Martin; M Cotard; J P Mialot; F André; J P Raynaud
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

9.  Estrogen-receptor status and response to chemotherapy in early and advanced breast cancer.

Authors:  G Bonadonna; P Valagussa; G Tancini; G Di Fronzo
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

10.  Immunocytochemical staining of estrogen receptor in paraffin sections of human breast cancer by use of monoclonal antibody: comparison with that in frozen sections.

Authors:  A Shimada; S Kimura; K Abe; K Nagasaki; I Adachi; K Yamaguchi; M Suzuki; T Nakajima; L S Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.